STOCK TITAN

Ipsen: Disclosure Transaction in Own Shares Between 18/07/2022 to 22/07/2022

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

PARIS--(BUSINESS WIRE)-- Regulatory News:

Aggregated presentation by day and market
 

Issuer name

Issuer identification code

Transaction date

Identification code of the
financial instrument

Daily total volume (in
number of shares)

Daily weighted
average price of
shares acquired

Platform

IPSEN

549300M6SGDPB4Z94P11

18/07/2022

FR0010259150

4 500

92,4055

XPAR

IPSEN

549300M6SGDPB4Z94P11

20/07/2022

FR0010259150

1 500

92,5337

XPAR

IPSEN

549300M6SGDPB4Z94P11

21/07/2022

FR0010259150

611

92,5646

XPAR

IPSEN

549300M6SGDPB4Z94P11

22/07/2022

FR0010259150

2 300

92,4132

XPAR

 

 

 

TOTAL

8 911

92,4400

 

 

For further information:

Craig Marks

Vice-President Investor Relations

Tel.: +44 (0) 7584 349 193

E-mail: craig.marks@ipsen.com

Fabien Puibarreau

Head of Company Law and Securities Law

Tel.: +33 (0)1 58 33 58 86

E-mail: fabien.puibarreau@ipsen.com

Source: Ipsen

Ipsen Sa

OTC:IPSEY

IPSEY Rankings

IPSEY Latest News

IPSEY Stock Data

11.52B
330.84M
0.01%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
France
Boulogne-Billancourt